Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: Behav Ther. 2023 Mar 16;54(5):839–851. doi: 10.1016/j.beth.2023.03.001

A Randomized Community-Based Trial of Behavior Therapy vs. Usual Care for Adolescent ADHD: Secondary Outcomes and Effects on Comorbidity

Margaret H Sibley 1, Paulo A Graziano 2, Stefany J Coxe 2, Leonard Bickman 3, Pablo Martin 2, Sabrina Flores 4
PMCID: PMC10440417  NIHMSID: NIHMS1898777  PMID: 37597961

Abstract

Though behavior therapy (BT) for ADHD is evidence-based in adolescence, almost no work examines its implementation and effectiveness in community settings. A recent randomized community-based trial of an evidence-based BT for adolescent ADHD (Supporting Teens’ Autonomy Daily; STAND; N=278) reported high clinician, parent, and youth acceptability but variable implementation fidelity. Primary outcome analyses suggested no significant differences between STAND and usual care (UC) unless the clinician delivering STAND was licensed. The present study reports secondary outcomes for this trial on indices of comorbidity (anxiety, depression, oppositional defiant disorder, conduct disorder) and ADHD outcomes not targeted by the active treatment (social skills, sluggish cognitive tempo). We also examine whether therapist licensure moderated treatment effects (as in primary outcome analyses). Using intent-to-treat and per protocol linear mixed models, patients randomized to STAND were compared to those randomized to UC over approximately 10 months of follow-up. Group × time effects revealed that, overall, STAND did not outperform usual care when implemented by community clinicians. However, a group × time × licensure interaction revealed a significant effect on conduct problems when STAND was delivered by licensed clinicians (d=.19 – .47). When delivered in community settings, behavior therapy for adolescent ADHD can outperform UC with respect to conduct problems reduction. Community mental health clinics should consider: (1) assigning adolescent ADHD cases to licensed professionals to maximize impact and (2) choosing psychosocial approaches when ADHD presents with comorbid conduct problems. There is also a need to reduce implementation barriers for unlicensed clinicians in community settings.


There are two classes of evidence-based treatments for Attention Deficit/Hyperactivity Disorder (ADHD) in adolescence: pharmacological and psychosocial (Chan et al., 2016; Sibley et al., 2014). Pharmacological treatments demonstrate acute efficacy in addressing ADHD symptoms but seem to face patient acceptability issues in adolescence (Bangs et al., 2007; Brinkman et al., 2018; Findling et al., 2011; Klorman et al., 1990; Spencer et al., 2006). Most teenagers desist childhood ADHD medications by high school and report negative beliefs about their utility and side effects (Brinkman et al., 2018; Molina et al., 2009). Psychosocial treatments for ADHD in adolescence emerged in the last decade that include youth-directed organization and time management skills training to address executive function deficits paired with contingency management to address motivation deficits (Chan et al., 2016; Rios-Davis et al.; Sibley et al., 2014). Multiple randomized controlled trials (RCTs) substantiate the efficacy of these treatment packages on gold standard measures of ADHD symptoms when compared to untreated control groups (Evans et al., 2016; Langberg et al., 2012; Sibley et al. 2016; Sprich et al., 2016). Although psychosocial treatments for adolescent ADHD appear more palatable to youth, attempts to export them into the community setting led to poor uptake, potentially due to burdens associated with delivering these models (Evans et al., 2007; Sibley, Olson, et al., 2016).

To carefully study, and eventually improve implementation of, community-delivered, evidence-based psychosocial treatment for adolescent ADHD, we recently conducted a first community-based trial of a psychosocial treatment for this population. Specifically, we conducted a hybrid implementation-effectiveness trial of Supporting Teens’ Autonomy Daily (STAND; Sibley, 2016) delivered by practitioners in four community mental health agencies and compared to agency usual care (Sibley, Graziano, Coxe, et al., 2021). STAND primarily targets the impact of ADHD symptoms on school and family impairment (Sibley, Johansson, et al., 2022) by blending behavior therapy approaches with Motivational Interviewing (MI; Miller & Rollnick, 2013) that targets engagement. STAND’s implementation features were selected to promote translation into real-world settings: (1) an insurance billing compatible service delivery model, (2) a simple step by step manual and family activity workbooks, and (3) content that can be delivered with fidelity by even beginner therapists (Sibley et al., 2016). STAND is a 10-session modular therapy that honors the heterogeneity of adolescent ADHD by allowing families to self-select into organization, time management, and planning (OTP), communication skills, and behavioral contracting modules that infuse MI strategies such as goal setting and implementation intentions, identifying patient values, reinforcing patient language about change, and mental contrasting (Miller & Rollnick, 2013). Three randomized controlled trials (RCTs) in university settings support STAND’s acceptability, patient-engagement, and efficacy compared to treatment as usual, as well as standard evidence-based behavior therapy for adolescent ADHD for certain families (Sibley et al., 2013; Sibley et al., 2016; Sibley, Rodriguez, et al., 2020).

In our community-based trial of STAND, there were no differences in the amount of therapy delivered to youth in the STAND vs. usual care groups, but that parents were significantly better engaged in STAND than usual care. Community practitioners found the intervention acceptable to deliver and easier than usual care practices (potentially because the treatment manual provides a step-by-step guide to implementation); however, implementation fidelity was variable and correlated with patient outcomes (Sibley, Graziano, Bickman, et al., 2021). Specifically, content fidelity for STAND was adequate in the treatment’s initial engagement and skills training phases but was poor during the intervention’s final planning phase. MI strategies were implemented at a significant higher rate in the STAND vs. usual care group, but the STAND group’s MI integrity was notably lower than in STAND’s previous efficacy trials (when treatment was delivered by university trainees). Content fidelity, in particular, correlated with impairment outcomes within the STAND group, indicating that those who received treatment delivered with higher fidelity demonstrated better treatment outcomes (Sibley, Bickman, et al., 2021).

Most patients and parents adequately engaged in community-delivered STAND. However, on key patient outcomes (i.e., ADHD symptom severity, impairment indices), STAND only outperformed usual care when clinicians were licensed (this effect was unrelated to length of time practicing). In the U.S., therapists who have not received a license to practice from their state department of health often comprise most of the community mental health workforce (Schoenwald et al., 2008) because they are lower cost to employ than those who are licensed. We hypothesized that licensed clinicians were more skilled and professionally engaged than their counterparts who had not chosen to obtain a practitioner’s license, leading to higher quality intervention (Daniels, 2002). Unlicensed clinicians, who comprised most of the sample, delivered a version of STAND that was significantly less effective. Based on these results, we concluded that additional efforts were needed to support implementation of psychosocial treatments for adolescent ADHD by the largely unlicensed community mental health workforce (Schoenwald et al., 2008). Following the trial’s conclusion, we conducted an Innovation Tournament with community mental health stakeholders to identify barriers to intervention fidelity and strategies to improve implementation quality (Sibley, Ortiz, et al., 2022). Our work to build and test a new implementation model for STAND is ongoing (Sibley, Bickman, et al., in press).

Following publication of the trial’s main results, we turned our interest toward better understanding usual care, and the extent to which evidence-based versus low value practices were typically implemented by community clinicians. Sibley, Reyes Francisco, et al (2022) conducted a detailed content analysis of audio recordings of usual care therapy sessions, finding that most practitioners implemented low-value ADHD practices characterized by high levels of social skills training, youth-directed therapy without parental involvement, and failure to assign therapy homework. Some practitioners implemented evidence-based practices (most commonly time management skills training), but typically did so with very low thoroughness. Despite the apparent limitations of usual care, one benefit was its flexibility; practitioners were free to address comorbidities and target behaviors outside of the manualized content prescribed by STAND. Therefore, it is possible that usual care could have insufficiently addressed ADHD symptom severity and academic and family functioning (Sibley, Reyes Francisco, et al., 2022), while still successfully treating other outcomes that were not targeted by STAND. For example, despite a research team ADHD diagnosis being a trial inclusion criterion, agencies assigned a primary diagnosis of ADHD to only 53.3% of the youth who were enrolled in the community-based STAND RCT (Sparber et al., 2022). The most common alternative diagnoses were depression disorders (7.2%), anxiety disorders (4.3%), oppositional defiant disorder (ODD; 5.8%), and conduct disorder (4.0%). As a result, usual care agency treatment plans may have targeted comorbidities instead of ADHD when staff deemed these presenting problems to be more urgent. Similarly, usual care may have targeted ADHD-related domains of impairment that are not targeted by STAND (e.g., social skills deficits, sluggish cognitive tempo; SCT).

It is also possible that community-delivered STAND offered secondary effects on comorbidities and non-targeted ADHD-related outcomes. For example, school-based behavior therapy for ADHD has been shown to positively impact parent ratings of ODD at home (Evans et al., 2011) as well as internalizing problems and child reported conduct problems (Molina et al., 2008), and sluggish cognitive tempo (SCT; Smith & Langberg, 2020). Previously, a lab-based RCT of STAND also demonstrated impact on parent-reported ODD, despite not directly targeting oppositional behaviors in treatment (Sibley et al., 2013). While comorbid disorders are not explicitly treated in STAND, parent-teen communication skills training may have a secondary impact on youth social skills. Similarly, behavioral contracting may have a secondary impact ODD or CD-related behaviors if parents request to include these targets in the individualized behavioral contracts. Time management or homework skills training may improve SCT symptoms while reduction of impairment may relieve anxiety and depression that is driven by problems at home or school. Therefore, an analysis of secondary outcomes is necessary to fully understand the impact of evidence-based psychosocial treatment for ADHD delivered in community settings.

The purpose of the present study is to gain broader understanding of the potency of community-based usual care for adolescent ADHD, as well as potential secondary effects of community-delivered STAND, on non-targeted patient outcomes. Herein, we conduct secondary intent to treat (ITT) and per protocol (PP) analyses that compare STAND vs. Usual Care on six secondary patient outcomes: youth-reported depression and anxiety and parent-reported ODD, CD, SCT, and social problems. We also evaluated whether the previously detected group × time × licensure effect generalized to secondary outcomes. We hypothesized that usual care would be of higher value to STAND on depression, anxiety, and social skills outcomes because depression and anxiety are more likely to be directly addressed in UC (vs. STAND) and social skills training was the most commonly delivered element of UC (Sibley, Reyes, Francisco, et al., 2022). We further hypothesized that when clinicians were licensed, STAND would outperform UC for ODD, CD, and SCT, because behavior therapy for ADHD may target these symptom clusters in an indirect way, and, when implemented with fidelity, similar therapies have demonstrated effects on these indices (Evans et al., 2011; Molina et al., 2008; Sibley et al., 2013; Smith & Langberg, 2020).

Method

All procedures were approved by the Florida International University Institutional Review Board. Parents, therapists, and adolescents signed consent/assent documents prior to participating.

Participants

Adolescents.

Adolescents (N=278; ages 11–17) were incoming patients at four community agencies in a large pan-Latinx and pan-Caribbean U.S. city. They were required to meet full DSM-5 ADHD criteria using a structured diagnostic interview and parent and teacher rating scales. These procedures have been described at length elsewhere (Sibley, Graziano, Coxe, et al., 2021). Autism spectrum disorder and intellectual disability (IQ<70) were exclusionary. Adolescents were randomly assigned to STAND or UC using a stratified randomization procedure within agency. Randomization occurred after agency and study intake and before initiation of treatment at the agency (see Sibley, Graziano, Coxe, et al., 2021). Table 1 presents sample demographic characteristics. There were no significant group differences on any variable.

Table 1.

Baseline Characteristics of Adolescent Sample

STAND (N=138) UC (N=140)
Diagnostic Variables
WASI estimated Full-Scale IQ M(SD) 94.15(14.07) 96.81(13.20)
ADHD Presentation
 ADHD-Predominantly Inattentive (%) 50.0 54.3
 ADHD-Combined (%) 50.0 45.7
ODD 49.3 46.4
CD 7.2 2.9
Elevated Depressive Symptoms 21.0 12.2
Elevated Anxiety Symptoms 21.0 15.8
Current ADHD Medication (%) 31.2 23.6
Demographic Variables
Age M(SD) 13.97(1.51) 14.08(1.50)
Male Patients (%) 70.3 70.7
Race/Ethnicity (%)
 White Non-Hispanic 5.1 3.6
 Black Non-Hispanic 16.7 10.0
 Hispanic Any Race 77.5 85.7
 Other 0.7 0.7
Single Parent (%) 35.5 36.4
Limited Parent English Proficiency (%) 36.2 46.4
Billing Source (%)
 Medicaid 57.0 55.0
 State/County Subsidy 12.2 14.4
 Sliding Scale 29.8 28.8
 Pro Bono 0.0 1.8
 Private Insurance 0.9 0.0
Parent Education Level
 High School Grad or less (%) 23.9 27.3
 Part College or Specialized Training (%) 30.4 30.2
 College or University Graduate (%) 33.3 33.1
 Graduate Professional Training (%) 12.3 9.4

Note. STAND=Supporting Teens Autonomy Daily; UC=Usual Care; WASI=Wechsler Abbreviated Scale of Intelligence; ADHD=Attention Deficit Hyperactivity Disorder; ODD=Oppositional Defiant Disorder; CD=Conduct Disorder M=Mean, SD=Standard Deviation; Elevated symptoms at baseline t-score > 65 on YSR depressed/withdrawn scale and anxiety problems scale.

Therapists.

Therapists (N=82) were mental health professionals employed at four agencies. Therapists were recruited on a rolling basis to accommodate the pace of patient enrollment and turnover of previously enrolled therapists. The number of therapists that ultimately enrolled and characteristics of these therapists (i.e., licensure status, therapist language, degree held) were allowed to vary naturalistically. Therapists self-identified as 19.8% non-Hispanic White (n=16), 14.8% Black or African-American (n=12), 64.2% Hispanic (n=53), and 1.2% Other (n=1). They were 86.6% female (n=71), with 61.0% (n=50) offering treatment in both Spanish and English. 86.6% (n=71) held a master’s degree [7.3% held a doctorate (n=6) and 6.1% were bachelor’s level interns (n=5)]. 22.0% of therapists (n=18) were licensed to practice by the state department of health and 78.0% were not. Unlicensed therapists included bachelor’s level, master’s level, and doctoral level practitioners. On average, clinicians reported 5.24 years delivering therapy (SD=5.00). STAND (N=44) and UC therapists (N=38) did not differ on any of the background variables noted above.

Procedures

Recruitment and Intake.

At agency intake, agency staff provided study information to parents of 6th-12th grade students with attention, organization, motivation, or behavior problems. Parents signed a permission to contact form and study staff administered an eligibility screen by phone that queried ADHD symptoms, impairment, exclusionary criteria, and treatment priority. If the research team deemed that another presenting problem (e.g., anxiety, substance use) took priority over ADHD, the teen was not eligible. Students with at least four inattention (IN) or hyperactivity/impulsivity (H/I) symptoms according to the screen attended a full diagnostic assessment to evaluate inclusion criteria. The study intake included an IQ screener (Wechsler Abbreviated Scale of Intelligence-2nd Edition; WASI-II; Wechsler, 2011) and parent-administered Diagnostic Interview Schedule for Children (DISC; Shaffer et al., 2000).

Therapist Recruitment.

Detailed information about therapist recruitment can be found in Sibley, Graziano, Bickman, et al., 2021. All therapists were randomly assigned to STAND or UC at baseline.

Intervention Content.

STAND is a manualized engagement-focused psychosocial treatment for adolescent ADHD. STAND consists of 10 weekly 60-minute sessions attended by the adolescent and parent (Sibley, 2016). Skill instruction is blended with MI and guided parent-teen behavioral contracting. Treatment targets family, behavioral, and academic impairment. Treatment is modular to promote flexibility and treatment tailoring. In the engagement phase, MI increases awareness of personal values and goals, identifies strengths, and recognizes ways to achieve personal goals and act consistently with values. The skills phase teaches parent-teen communication, parent behavioral strategies, and organization, time management and planning skills applied to homework, school, and chores. Planning sessions teach families to integrate skills into a daily routine, transfer new habits to school settings, and build a final parent-teen contract. MI in the final session promotes maintenance of change.

Therapist Procedures.

Therapy was delivered across three years. Duration of treatment varied naturalistically to avoid built-in between-group dose differences. Participating therapists treated an average of 2.74 study cases (range: 0 to 14). Study interventions were provided by agency employees using typical billing procedures. Therapists randomized to STAND were offered a three-day training and 30-minutes of weekly supervision while treating study cases. Every 12 months, a four-hour booster training was provided. STAND therapists were provided with a treatment manual and a family workbook for each case. Therapists in both groups were instructed to utilize usual care procedures for termination, allowing STAND therapists to continue treatment after completing STAND manualized content. UC therapists were instructed to treat study cases using usual procedures in the agency and the treatments they believed would be most effective for the youth. They received weekly supervision for study cases from agency supervisors according to typical agency practices. UC therapists were offered STAND training at study conclusion. Fidelity and differentiation data is presented elsewhere (Sibley, Graziano, Bickman, et al., 2021; Sibley, Graziano, Coxe, et al., 2021).

Data Collection.

Participants were permitted to utilize naturalistic stimulant medication during the study; all medications were monitored and controlled for in analyses. Because therapy duration was allowed to vary naturalistically, PT assessments were scheduled for 16 weeks after the participant’s first session at the agency, which provided ample time for families to complete the 10 session STAND protocol with assumed cancellations. On average, PT assessments occurred 5.11 months after BL (SD=2.26). FU assessments were attempted at approximately 12 weeks after PT. On average, FU assessments occurred approximately 4.70 months after PT (SD=2.50). Retention was 99.3% (n=276) at PT and 97.5% (n=271) at FU (data provided by at least one informant). Electronic health records were accessed directly. Parent ratings were available in Spanish or English. Families received $100 for each assessment.

Measures

Outcomes.

The Child Behavior Checklist- Ages 6–18 (CBCL; Achenbach, 2009) was used to measure social problems, sluggish cognitive tempo (SCT), oppositional defiant problems (ODD), and conduct problems. The Youth Self Report, Ages 11–18 (YSR; Achenbach & Rescorla, 2001) was used to assess depressive (withdrawn/depressed) and anxiety problems. Both the Youth Self-Report (YSR) Achenbach and CBCL produce T-Scores in eight empirically based syndrome subscales and six DSM-oriented scales. Respondents answer each item on a 0 (never) to 2 (often) scale. All CBCL and YSR scales have excellent internal consistency, test-retest reliability and validity (Achenbach & Rescorla, 2001). In the current study, alpha for each subscale was as follows: Social Problems (11 items; e.g., not getting along with others, teased, prefers younger children, not well-liked)=.72, SCT (4 items; e.g., daydreams, lacks energy, stares, acts confused)=.67, ODD (5 items; e.g., argues with others, disobeys, stubborn)=.80, Conduct Problems (17 items; e.g., property destruction, breaks rules, lying, stealing, threatening people)=.81, Depression (8 items; e.g., sad, withdrawn, enjoys very little)=.74, Anxiety Problems (9 items; e.g., nervous, fearful, worries)=.78.

Licensure.

Therapists self-reported their licensure status at enrollment into the trial. No therapists changed licensure status during the trial. Licensure was coded as 0=not licensed and 1=licensed.

Analytic Plan

Linear mixed models (LMMs) with random intercepts were conducted in SPSS 25. We first conducted intent to treat analyses (N=278). Separate LMMs were conducted for each outcome and dummy codes were specified for group (UC=0, STAND=1). We included three dummy codes with agency 1 (largest) serving as the reference group. We tested various time curves and found linear time to possess the best fit. Time was coded as a continuous, subject-specific measure reflecting months since BL (BL time=0). Data were assumed missing at random (MAR; Schafer & Graham, 2002). A full information robust Maximum Likelihood estimator was employed. For each outcome, the following specifications were evaluated. The linear effects of time and group × time were the effects of interest to test aim 1 hypotheses.

  • Level 1: Yij = π0i+π1(time)+eij

  • Level 2: π0i = β00+β01(agency 2)+β02(agency 3)+β03(agency 4)+β04(group)+r0i π1 = β10+β11(group)

  • Combined: Yij=β00+ β01(agency 2)+β02(agency 3)+ β03(agency 4)+β10(group)+β11(group*time)+r0i+eij

We then conducted per protocol (PP) analyses that included only participants who initiated treatment (n=225). This analysis isolates the upper limit on true effects of STAND in community settings, given that ITT effects may be deflated by randomized participants who never engaged in services. Compared to those who initiated treatment, those who did not (N=53) did not differ on demographic or clinical variables listed in Table 1. All analyses above were repeated and three-way interactions of licensure × group × time indicated whether the group’s effect on the mechanism over time varied by licensure.

Results

Social Problems

For both the ITT and PP analyses there were no significant group × time interactions for parent-reported social skills. However, both groups demonstrated significant reductions in social problems over time in both ITT and PP analyses (see Table 2). There was no significant group × time × licensure interaction (see Table 3).

Table 2.

Intent to Treat (ITT) and Per Protocol (PP) Analyses: Results from Linear Mixed Models

STAND UC Time Group × Time
BL M (SD) PT M (SD) FU M (SD) d BL M (SD) PT M (SD) FU M (SD) d b (SE) P 95% CI b (SE) P d a 95% CI
ITT (N=278)
Social Problems 59.69(8.02) 57.91(7.59) 56.10(7.61) .45 60.01(8.29) 58.86(7.43) 57.68(8.19) .28 −.19(.06) .001 −.31 to −.08 −.10(.08) .208 .15 −.26 to .06
SCT 60.25(8.70) 58.63(7.87) 56.98(7.91) .38 59.26(8.02) 57.90(7.45) 56.51(7.96) .34 −.23(.06) <.00 1 −.35 to −10 −.04(.09) .622 .06 −.21 to .13
ODD 59.56(8.42) 57.98(7.85) 56.37(7.63) .44 58.36(7.65) 57.02(7.61) 55.66(7.05) .35 −.22(.06) <.001 −.34 to −.11 −.04(.08) .620 .06 −.20 to .12
Conduct 57.37(7.17) 56.69(6.91) 56.01(7.27) .19 56.78(6.62) 56.11(7.14) 55.42(6.55) .21 −11(05) .017 −.20 to −.02 .00(.06) 1.00 .00 −.13 to .13
ProblemsDepression 57.80(9.55) 57.15(7.71) 56.48(7.78) .14 56.53(8.28) 55.96(6.85) 55.37(8.73) .14 −.10(.07) .147 −.23 to .04 −.01(.09) .888 .02 −.19 to .17
Anxiety 56.75(8.11) 55.26(7.08) 53.73(6.57) .37 56.12(7.06) 55.42(7.04) 54.72(7.40) .20 −.12(.06) .057 −.23 to .00 −.13(.08) .105 .21 −.30 to .03
PP (N=225) 60.19(8.10) 58.46(7.78) 56.70(7.87) .43 59.39(8.04) 58.20(7.09) 57.00(7.67) .15 −.20(.07) .005 −.34 to −.06 −.09(.09) .337 .14 −.27 to .09
Social Problems 60.06(8.57) 58.69(7.78) 57.30(8.01) .32 59.44(8.02) 57.82(7.64) 56.16(7.71) .41 −.27(.07) <.001 −.42 to −.12 .04(.10) .666 −.06 −.15 to .24
ODD 59.33(8.30) 57.90(7.58) 56.44(7.13) .35 58.24(7.61) 56.66(7.21) 55.04(6.63) .42 −.26(.07) <.001 −.40 to −.13 .03(.09) .783 −.04 −.16 to .21
Conduct Problems 57.14(7.26) 56.65(6.70) 56.15(7.08) .14 56.29(6.17) 55.43(6.16) 54.56(5.88) .28 −.14(.05) .008 −.25 to −.04 .06(.07) .389 −.11 −.08 to .20
Depression 58.47(10.07) 57.66(7.90) 56.84(7.98) .16 56.85(8.55) 56.27(7.00) 55.67(9.24) .14 −.10(.08) .218 −.25 to .06 −.04(.11) .727 .11.05 −.24 to .17
Anxiety 56.76(8.34) 55.40(6.85) 54.00(6.81) .33 56.27(7.14) 55.41(7.19) 54.52(7.28) .25 −.15(.07) .040 −.28 to −.01 −.08(.09) .376 .13 −.27 to .10

Note. BL=baseline; PT=post-treatment; FU=follow-up; SCT=Sluggish cognitive tempo; ODD= oppositional defiant disorder; Means are marginal estimates controlling for agency. Cohen’s d within groups is difference between BL and FU divided by baseline pooled standard deviation. Significant p-values noted in bold. alpha=05.

a

difference between group change scores divided by baseline pooled standard deviation

Table 3.

Licensure Moderation Analyses

Time × Licensure Group × Time × Licensure
b SE p 95% CI b SE p 95% CI
Social Problems −.03 .16 .832 −.35 to .28 −.20 .22 .351 −.63 to .22
SCT −.14 .17 .406 −.48 to .19 .14 .23 .545 −.31 to .59
ODD .01 .16 .949 −.30 to .32 −.27 .21 .206 −.68 to .15
Conduct Problems .11 .12 .380 −.13 to .35 −.37 .16 .026 −.69 to −.05
Depression .31 .18 .094 −.05 to .66 .06 .24 .814 −.42 to .54
Anxiety −.09 .16 .579 −.41 to .23 .11 .22 .607 −.32 to .54

Note. SCT=Sluggish cognitive tempo; ODD= oppositional defiant disorder; bold values indicate statistical significance (p<.05)

Sluggish Cognitive Tempo

For both the ITT and PP analyses there were no significant group × time interactions for parent-reported SCT. However, both groups demonstrated significant reductions in SCT over time in both ITT and PP analyses (see Table 2). There was no significant group × time × licensure interaction (see Table 3).

Oppositional Defiant Problems

For both the ITT and PP analyses there were no significant group × time interactions for parent-reported ODD. However, both groups demonstrated significant reductions in ODD over time in both ITT and PP analyses (see Table 2). There was no significant group × time × licensure interaction (see Table 3).

Conduct Problems

For both the ITT and PP analyses there were no significant group × time interactions for parent-reported conduct problems (see Table 2). However, both groups demonstrated significant reductions in conduct problems over time in both ITT and PP analyses (see Table 2). In addition, there was a significant group × time × licensure interaction (see Table 3 & Figure 1) indicating that the combination of STAND and a licensed therapist led to the greatest reductions in conduct problems over time (p=.026). Standardized difference scores for 3-way interactions were d=.38 (STAND licensed vs. UC licensed), d=.19(STAND licensed vs. UC unlicensed), and d=.47 (STAND licensed vs. STAND unlicensed).

Figure 1.

Figure 1.

Group × Time × Licensure Interaction for Conduct Problems Outcome

Note. BL=baseline; PT=post-treatment; FU=follow-up

Depression

For both the ITT and PP analyses there were no significant group × time interactions for youth-reported depression. However, both groups demonstrated significant reductions in depression over time in both ITT and PP analyses (see Table 2). There was no significant group × time × licensure interaction (see Table 3).

Anxiety

For both the ITT and PP analyses there were no significant group × time interactions for youth-reported anxiety. However, both groups demonstrated significant reductions in depression over time in the PP analyses, but not the ITT analyses (see Table 2). There also was no significant group × time × licensure interaction (see Table 3).

Discussion

There were several findings of this study. First, despite its flexibility to address a greater range of presenting problems than manualized STAND, community-based UC for adolescent ADHD did not outperform STAND on indices of comorbidity (anxiety, depression, conduct problems, ODD) or ADHD-related targets outside STAND’s scope (social problems, SCT). Second, we replicated previous findings on four other outcomes in this trial (ADHD symptoms, organization, time management, and planning skills, parent academic involvement, adolescent motivation; Graziano et al., revise and resubmit; Sibley, Graziano, Coxe, et al., 2021) showing that the most effective condition in this trial was STAND delivered by licensed providers (d=.19 to .47)— extending the previously detected group × time × licensure interactions to conduct problems (Sibley, Graziano, Coxe, et al., 2021). However, licensed therapists delivering STAND did not demonstrate greater efficacy on other indices of comorbidity or targets outside the scope of STAND. We discuss these findings below.

The results of this study suggest that both STAND and UC improved on all secondary outcomes over time (see Table 2). Therefore, it is possible that both conditions exerted an equal positive effect on these indices. For example, evidence-based psychosocial treatment targeting adolescent ADHD symptoms may have had indirect impacts on internalizing symptoms or externalizing problems by improving the executive function or motivation deficits that can lead to demoralization, anxiety, interpersonal problems, and choosing deviancy over academic engagement (Evans et al., 2011; Molina et al., 2008; Sibley et al., 2013; Smith & Langberg, 2020). On the other hand, there is some evidence that clinicians delivering UC directly targeted outcomes such as social skills, SCT (through time management training), as well as anxiety (Sibley, Reyes Francisco, et al., 2022). Despite these possibilities, we cannot be confident that treatment is the reason for the significant effects of time. Confounding factors are known to produce changes in ADHD-related indices over time in non-inferiority trials (i.e., regression to the mean, maturation, placebo effects, baseline symptom exaggeration by raters who want to ensure acceptance into a study). Though active control groups, such as UC, are encouraged in ADHD RCTs to promote patient blinding (Sonuga-Barke et al., 2013), non-inferiority trials also introduce differentiation issues that can make it challenging to interpret null effects. Thus, future work is needed to compare both UC and community-delivered STAND to non-active control groups and to identify creative study designs that can elucidate their relative potency while minimizing confounds.

As with the primary outcomes of this trial (Sibley, Graziano, Coxe, et al., 2021) and its mechanistic effects (Graziano et al., revise and resubmit), STAND delivered by a licensed therapist was associated with significantly greater reductions in conduct problems compared to UC and unlicensed therapists delivering STAND (see Figure 1). The average standardized effect size for the three-way interaction was approximately d=.35 and demonstrates clinical significance given that the average effect of behavioral treatments for adolescent ADHD on conduct problems is approximately d=.34 (Sibley et al., 2014). Previous attempts to explain this effect found that licensure status was not significantly related to therapist knowledge, competence, participation in training, supervision attendance, content fidelity, MI implementation, or therapeutic alliance (Sibley, Graziano, Coxe, et al., 2021). We hypothesize that licensed clinicians were more skilled and professionally engaged than their counterparts who had not chosen to obtain a practitioner’s license, leading to higher quality care that may be non-specific to our fidelity indices (Daniels, 2002). Because the majority of the community mental health workforce is unlicensed, our collaborative work with stakeholders moving forward has been focused on identifying implementation barriers and strategies to support high quality delivery of care for unlicensed clinicians (Sibley, Ortiz, et al., 2022).

Overall, our findings suggest that of all the non-targeted indices we tested, conduct problems benefited most from evidence-based ADHD treatment delivered in a community setting. In our sample, factor loadings for the conduct problems dimension were strongest for items such as property destruction, breaks rules, lying, stealing, and threatening people. Molina and colleagues (2008) demonstrated that a school-based intervention for adolescent ADHD reduced conduct problems; however, this is the first RCT to demonstrate that a clinic-based intervention for adolescent ADHD reduces conduct problems. Another clinic-based intervention to use the parent-youth model (parent-child interaction therapy) also demonstrated effects on conduct problems in an RCT with younger children (Matos et al., 2009). Meta-analysis suggests that comorbid CD predicts poorer response to behavior therapy for ADHD (Groenman et al., 2022). Thus, it is promising that the parent-teen model may have a secondary effect of simultaneously mitigating conduct problems and ADHD in community settings. This finding fits with the family-based paradigm that is the primary evidence-based modality in the treatment of conduct disorder (Fairchild et al., 2019).

Perhaps somewhat surprisingly, the group × licensure × time effect was not also present for two outcomes that seem to be naturally targeted by STAND: SCT and ODD. In its initial efficacy RCT, STAND was shown to significantly impact ODD symptoms over time, though with effects smaller than for main outcomes (Sibley et al., 2013). Though SCT has not previously been tested as an outcome for STAND, similar behavior therapies for ADHD that focus on executive functioning and motivation show effects on SCT outcomes (Breaux et al., 2020). Overall, the effect sizes for outcomes previously demonstrating the group × time × licensure interaction in this trial (ADHD symptoms, organization, time management and planning skills, adolescent motivation to change, parent academic involvement; Graziano et al., revise and resubmit; Sibley, Graziano, Coxe, et al., 2021) are the primary targets of the intervention and tended to have the largest effect sizes in our university efficacy trials. Given that all time effects appear to be significantly diminished in the community setting (at least in part due to fidelity problems; Sibley, Bickman, et al., 2021), we hypothesize that smaller effects did not survive this diminishing. Thus, it is hoped that our continued work to improve implementation fidelity in community settings will lead to stronger impacts on secondary variables like ODD and SCT.

As adaptation and iterative implementation of evidence-based treatments for ADHD continues in community settings, the collective results of the STAND community study emphasize that who delivers treatment appears to matter. With high turnover, few continuing education resources, and largely unlicensed workforces (Garland et al., 2010; Schoenwald et al., 2008), community mental health settings may need extra supports to launch evidence-based practice initiatives for ADHD. Licensed therapists, who appear best suited for effective delivery of evidence-based care for ADHD (see Table 2), may be under-represented in community settings (just 22% of therapists in our sample; Sibley, Graziano, Bickman, et al., 2021). Intervention researchers in the field of ADHD, as well as community implementation specialists, are encouraged to identify factors that may improve treatment delivery by unlicensed therapists. Implementation science frameworks may provide useful tools for doing so (e.g., Moullin et al., 2019). For example, after an Innovation Tournament with therapist stakeholders, our team is rebuilding the STAND implementation strategy based on therapist input. As part of this we are investigating the utility of an artificial intelligence application to provide on-demand fidelity feedback to therapists delivering ADHD intervention in community settings (Sibley, Bickman, et al., in press). Though replication of our licensure effect remains critical, in the meantime, community mental health administrators may consider prioritizing ADHD cases for licensed clinicians when doing so is practical. Furthermore, given only limited evidence that stimulant medications for ADHD directly mitigates adolescent conduct problems (Efron et al., 1997; Kaplan et al., 1990; Klein et al., 1997), psychosocial treatment may be an appropriate choice for adolescents with ADHD and comorbid CD who present in community settings.

This study has several important limitations. Therapist participation was voluntary, and we may have oversampled therapists with openness to evidence-based treatments. It was not possible to mask therapists or participants to group, though they were masked to hypotheses. Therapist to client ratio was low in this trial (i.e., 1:2.74) due to high turnover in community contexts and fine-grained patient-therapist matching that required consideration of agency, parent language, therapist catchment area, and insurance type. As a result, we did not cluster within therapist in analyses (though we covaried for agency). Additionally, we did not assess psychological service utilization outside of the agencies. Some comorbid symptom clusters were in the non-clinical range at baseline for the majority of the sample (see Table 1); results might be different in youth purposefully sampled for comorbidities.

This study offers evidence that psychosocial treatment for adolescent ADHD, delivered in community settings, can outperform UC with respect to reducing conduct problems. Despite this promising effect, treatment was only successful when delivered by licensed clinicians, who are often under-represented in the community mental health workforce (Schoenwald et al., 2008). Community mental health clinics should consider assigning adolescent ADHD cases to advanced clinicians (such as licensed professionals) and should consider treating cases with ADHD and comorbid conduct problems with psychosocial treatment. Researchers developing ADHD treatments for community settings should consider efforts to enhance the deliverability of evidence-based treatments by a primarily unlicensed workforce. This adaptation may require changes to the content, process, structure, and implementation supports of treatment.

Highlights.

  • Community treatment for ADHD was most effective when delivered by licensed clinicians.

  • Behavior therapy for ADHD outperformed usual care for conduct problems and may be particularly effective for these youth.

  • Clinics might assign adolescent ADHD cases to licensed professionals.

  • All other comorbidity outcomes did not show group differences between STAND and usual care.

Footnotes

Conflict of Interest: Dr. Sibley receives royalties from Guilford Press for a book describing the treatment evaluated in this research. No other authors report conflicts of interest.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Achenbach TM (2009). The Achenbach System of Empirically Based Assessment (ASEBA): Development, findings, theory, and applications. University of Vermont Research Center for Children, Youth, & Families. [Google Scholar]
  2. Achenbach TM, & Rescorla LA (2001). Manual for the ASEBA school-age forms & profiles. University of Vermont, Research Center for Children, Youth, & Families. [Google Scholar]
  3. Bangs ME, Emslie GJ, Spencer TJ, Ramsey JL, Carlson C, Bartky EJ, et al. (2007). Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. Journal of Child and Adolescent Psychopharmacology, 17, 407–419. 10.1089/cap.2007.0066 [DOI] [PubMed] [Google Scholar]
  4. Brinkman WB, Simon JO, & Epstein JN (2018). Reasons why children and adolescents with attention-deficit/hyperactivity disorder stop and restart taking medicine. Academic Pediatrics, 18(3), 273–280. 10.1016/j.acap.2017.09.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chan E, Fogler JM, & Hammerness PG (2016). Treatment of attention-deficit/hyperactivity disorder in adolescents: A systematic review. JAMA, 315(18), 1997–2008. 10.1001/jama.2016.5453 [DOI] [PubMed] [Google Scholar]
  6. Daniels (2002). The relationship between counselor licensure and aspects of empowerment. Journal of Mental Health Counseling, 24(3), 213–224. [Google Scholar]
  7. Efron D, Jarman F, & Barker M (1997). Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial. Pediatrics, 100(6), E6. 10.1542/peds.100.6.e6 [DOI] [PubMed] [Google Scholar]
  8. Evans SW, Langberg JM, Schultz BK, Vaughn A, Altaye M, Marshall SA, & Zoromski AK (2016). Evaluation of a school-based treatment program for young adolescents with ADHD. Journal of Consulting and Clinical Psychology, 84(1), 15. 10.1037/ccp0000057 [DOI] [PubMed] [Google Scholar]
  9. Evans SW, Schultz BK, Demars CE, & Davis H (2011). Effectiveness of the Challenging Horizons After-School Program for young adolescents with ADHD. Behavior Therapy, 42(3), 462–474. 10.1016/j.beth.2010.11.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Evans, Serpell ZN, Schultz BK, & Pastor DA (2007). Cumulative benefits of secondary school-based treatment of students with attention deficit hyperactivity disorder. School Psychology Review, 36(2), 256–273. 10.1080/02796015.2007.12087943 [DOI] [Google Scholar]
  11. Fairchild G, Hawes DJ, Frick PJ, Copeland WE, Odgers CL, Franke B, Freitag CM, & De Brito SA (2019). Conduct disorder. Nature Reviews. Disease Primers, 5(1), 1–25. 10.1038/s41572-019-0095-y [DOI] [PubMed] [Google Scholar]
  12. Findling RL, Childress AC, Cutler AJ, Gasior M, Hamdani M, Ferreira-Cornwell MC, & Squires L (2011). Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 50(4), 395–405. 10.1016/j.jaac.2011.01.007 [DOI] [PubMed] [Google Scholar]
  13. Garland AF, Hurlburt MS, Brookman-Frazee L, Taylor RM, & Accurso EC (2010). Methodological challenges of characterizing usual care psychotherapeutic practice. Administration and Policy in Mental Health, 37(3), 208–220. 10.1007/s10488-009-0237-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Groenman AP, Hornstra R, Hoekstra PJ, Steenhuis L, Aghebati A, Boyer BE, Buitelaar JK, Chronis-Tuscano A, Daley D, Dehkordian P, Dvorsky M, Franke N, DuPaul GJ, Gershy N, Harvey E, Hennig T, Herbert S, Langberg J, Mautone JA, Mikami AY, … Prof. Dr. van den Hoofdakker share last authorship and contributed equally to this work. (2022). An individual participant data meta-analysis: Behavioral treatments for children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 61(2), 144–158. 10.1016/j.jaac.2021.02.024 [DOI] [PubMed] [Google Scholar]
  15. Kaplan SL, Busner J, Kupietz S, Wassermann E, & Segal B (1990). Effects of methylphenidate on adolescents with aggressive conduct disorder and ADDH: A preliminary report. Journal of the American Academy of Child and Adolescent Psychiatry, 29(5), 719–723. 10.1097/00004583-199009000-00007 [DOI] [PubMed] [Google Scholar]
  16. Klein RG, Abikoff H, Klass E, Ganeles D, Seese LM, & Pollack S (1997). Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Archives of General Psychiatry, 54(12), 1073–1080. 10.1001/archpsyc.1997.01830240023003 [DOI] [PubMed] [Google Scholar]
  17. Klorman R, Brumaghim JT, Salzman LF, Strauss J, Borgstedt AD, McBride MC, & Loeb S (1990). Effects of methylphenidate on processing negativities in patients with attention-deficit hyperactivity disorder. Psychophysiology, 27(3), 328–337. 10.1111/j.1469-8986.1990.tb00391.x [DOI] [PubMed] [Google Scholar]
  18. Langberg JM, Epstein JN, Becker SP, Girio-Herrera E, & Vaughn AJ (2012). Evaluation of the Homework, Organization, and Planning Skills (HOPS) intervention for middle school students with ADHD as implemented by school mental health providers. School Psychology Review, 41(3), 342–364. 10.1080/02796015.2012.12087514 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Matos M, Bauermeister JJ, & Bernal G (2009). Parent-child interaction therapy for Puerto Rican preschool children with ADHD and behavior problems: A pilot efficacy study. Family Process, 48(2), 232–252. 10.1111/j.1545-5300.2009.01279.x [DOI] [PubMed] [Google Scholar]
  20. Molina BS, Flory K, Bukstein OG, Greiner AR, Baker JL, Krug V, & Evans SW (2008). Feasibility and preliminary efficacy of an after-school program for middle schoolers with ADHD: A randomized trial in a large public middle school. Journal of Attention Disorders, 12(3), 207–217. 10.1177/1087054707311666 [DOI] [PubMed] [Google Scholar]
  21. Molina B, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, Epstein JN, Hoza B, Hechtman L, Abikoff HB, Elliott GR, Greenhill LL, Newcorn JH, Wells KC, Wigal T, Gibbons RD, Hur K, Houck PR, & MTA Cooperative Group (2009). The MTA at 8 years: Prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child and Adolescent Psychiatry, 48(5), 484–500. 10.1097/CHI.0b013e31819c23d0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Moullin JC, Dickson KS, Stadnick NA, Rabin B, & Aarons GA (2019). Systematic review of the Exploration, Preparation, Implementation, Sustainment (EPIS) framework. Implementation Science:IS, 14(1), 1. 10.1186/s13012-018-0842-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rios-Davis A, Sibley MH, Delgado A, & Zulauf-McCurdy CA (2023). Identifying common, shared, and unique elements of evidence-based treatments for dolescent ADHD. Journal of Child and Family Studies 32, 466–480. 10.1007/s10826-022-02475-y [DOI] [Google Scholar]
  24. Schafer JL, & Graham JW (2002). Missing data: our view of the state of the art. Psychological Methods, 7(2), 147. 10.1037//1082-989X.7.2.147 [DOI] [PubMed] [Google Scholar]
  25. Schoenwald SK, Chapman JE, Kelleher K, Hoagwood KE, Landsverk J, Stevens J, Glisson C, Rolls-Reutz J, & Research Network on Youth Mental Health (2008). A survey of the infrastructure for children’s mental health services: Implications for the implementation of empirically supported treatments (ESTs). Administration and Policy in Mental Health and Mental Health Services Research, 35(1–2), 84–97. 10.1007/s10488-007-0147-6 [DOI] [PubMed] [Google Scholar]
  26. Shaffer D, Fisher P, Lucas CP, Dulcan MK, & Schwab-Stone ME (2000). NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): Description, differences from previous versions, and reliability of some common diagnoses. Journal of the American Academy of Child and Adolescent Psychiatry, 39(1), 28–38. 10.1097/00004583-200001000-00014 [DOI] [PubMed] [Google Scholar]
  27. Sibley MH, (2016). Parent-teen therapy for executive function deficits and ADHD: Building skills and motivation. Guilford. [Google Scholar]
  28. Sibley MH, Bickman L, Coxe SJ, Graziano PA, & Martin P (2021). Community implementation of MI-enhanced behavior therapy for adolescent ADHD: Linking fidelity to effectiveness. Behavior Therapy. 52(4), 847–860. 10.1016/j.beth.2020.10.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sibley MH, Bickman L Atkins D, Tanana M, Coxe SJ, Ortiz M, Martin P, King J, Monroy JM, Ponce T, Cheng J, Pace B, Zhao X, Chawla V, Page T (2023). Developing an implementation model for ADHD intervention in community clinics: Leveraging artificial intelligence and digital technology. Cognitive and Behavioral Practice. [Google Scholar]
  30. Sibley MH, Graziano PA, Coxe SJ, Bickman L, & Martin P (2021). Effectiveness of motivational interviewing-enhanced behavior therapy for adolescents with ADHD: A randomized community-based trial. Journal of the American Academy of Child & Adolescent Psychiatry, 60(6), 745–756. 10.1016/j.jaac.2020.07.907 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sibley MH, Graziano PA, Bickman L, Coxe SJ, Martin P, Rodriguez LM, Fallah N, & Ortiz M (2021). Implementing parent-teen motivational interviewing + behavior therapy for ADHD in community mental health. Prevention Science, 22(6), 701–711. 10.1007/s11121-020-01105-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sibley MH, Johansson M, Monroy JM, Hill DM, LaCount PA, Barney S, Molina N, & Delgado A (2022). Building a theoretical model for Supporting Teens’ Autonomy Daily (STAND): A network analysis of family-perceived changes. Behavior Therapy, 53(1), 49–63. 10.1016/j.beth.2021.05.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sibley MH, Kuriyan AB, Evans SW, Waxmonsky JG, & Smith BH (2014). Pharmacological and psychosocial treatments for adolescents with ADHD: An updated systematic review of the literature. Clinical Psychology Review, 34(3), 218–232. 10.1016/j.cpr.2014.02.001 [DOI] [PubMed] [Google Scholar]
  34. Sibley MH, Olson S, Morley C, Campez M, & Pelham WE Jr (2016). A school consultation intervention for adolescents with ADHD: Barriers and implementation strategies. Child and Adolescent Mental Health, 21(4), 183–191. 10.1111/camh.12159 [DOI] [PubMed] [Google Scholar]
  35. Sibley MH, Ortiz M, Rios-Davis A, Zulauf-McCurdy C, Graziano PA, & Bickman L (2022). Stakeholder-generated implementation strategies to promote evidence-based ADHD treatment in community mental health. Administration and Policy in Mental Health and Mental Health Services Research, 49, 44–58. 10.1007/s10488-021-01143-5 [DOI] [PubMed] [Google Scholar]
  36. Sibley MH, Graziano PA, Kuriyan AB, Coxe S, Pelham WE, Rodriguez LM et al. , (2016). Parent-teen behavior therapy + motivational interviewing for adolescents with ADHD. Journal of Consulting & Clinical Psychology, 84, 699–712. 10.1037/ccp0000106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sibley, Pelham WE, Derefinko KJ, Kuriyan AB, Sanchez F, & Graziano PA (2013). A pilot trial of Supporting Teens’ Academic Needs Daily (STAND): A Parent-adolescent collaborative intervention for ADHD. Journal of Psychopathology and Behavioral Assessment, 35(4), 436–449. 10.1007/s10862-013-9353-6 [DOI] [Google Scholar]
  38. Sibley MH, Reyes Francisco JC, Rios-Davis A, & Graziano PA (2022). Investigating routine care non-pharmacological treatment for adolescents with ADHD. Frontiers in Health Services. 10.3389/frhs.2022.929521 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sibley MH, Rodriguez LM, Coxe SJ, Page T, & Espinal K (2020). Parent-teen group versus dyadic treatment for adolescent ADHD: What works for whom? Journal of Clinical Child and Adolescent Psychology, 49, 476–492. 10.1080/15374416.2019.1585257 [DOI] [PubMed] [Google Scholar]
  40. Smith ZR, & Langberg JM (2020). Do sluggish cognitive tempo symptoms improve with school-based ADHD interventions? Outcomes and predictors of change. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 61(5), 575–583. 10.1111/jcpp.13149 [DOI] [PubMed] [Google Scholar]
  41. Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, Stevenson J, Danckaerts M, van der Oord S, Döpfner M, Dittmann RW, Simonoff E, Zuddas A, Banaschewski T, Buitelaar J, Coghill D, Hollis C, Konofal E, Lecendreux M, Wong IC, … European ADHD Guidelines Group (2013). Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. The American Journal of Psychiatry, 170(3), 275–289. 10.1176/appi.ajp.2012.12070991 [DOI] [PubMed] [Google Scholar]
  42. Sparber A, Tapia JD, Lopez O, Martin P, Graziano PA, & Sibley MH (2022, October). Investigating the relationship between community agency diagnoses and gold-standard diagnoses for adolescent ADHD [Poster presentation]. American Academy of Child and Adolescent Psychiatry 2022 Annual Meeting, Toronto, ON, Canada. [Google Scholar]
  43. Spencer TJ, Faraone SV, Biederman J, Lerner M, Cooper KM, Zimmerman B, & CONCERTA STUDY GROUP (2006). Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD?. Journal of the American Academy of Child and Adolescent Psychiatry, 45(5), 527–537. 10.1097/01.chi.0000205710.01690.d4 [DOI] [PubMed] [Google Scholar]
  44. Sprich SE, Safren SA, Finkelstein D, Remmert JE, & Hammerness P (2016). A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescents. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 57(11), 1218–1226. 10.1111/jcpp.12549 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Wechsler D (2011). Wechsler Abbreviated Scale of Intelligence–Second Edition (WASI-II). NCS Pearson. [Google Scholar]

RESOURCES